Hervé Brailly, Chairman of the Supervisory Board, co-founded Innate Pharma in 1999 and chaired its Executive Committee until December 30, 2016.
Hervé Brailly was previously a researcher at Immunotech SA, a biotechnology start up acquired in 1995 by Beckman-Coulter (1986-1994), where he later became responsible for marketing, business development and R&D, as well as the business activities in China (1994-1998). From 1998, Mr Brailly was the director of a business unit of the company with 65 employees and annual sales of 30 million U.S. dollars.
Hervé Brailly is a graduate of the Ecole des Mines de Paris (1983) and a Doctor of Immunology, with a specialization in immuno-pharmacology.
Hervé Brailly is member of the development council of the ”Marseille Provence Metropole”, the Strategy and Prospects Committee of Aix Marseille University.